Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

Details for Australian Patent Application No. 2004251522 (hide)

International Classifications

Event Publications

9 February 2006 PCT application entered the National Phase

PCT publication WO2005/000193 Priority application(s): WO2005/000193

16 June 2011 Application Accepted

Published as AU-B-2004251522

25 August 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 12 Jul 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2005

15 December 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Jul 2011 2005

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.